What was WeLeader Biomedical Co. Ltd.’s price range in the past 12 months?
WeLeader Biomedical Co. Ltd. lowest stock price was TWD 66.00 and its highest was TWD 81.10 in the past 12 months.
What is WeLeader Biomedical Co. Ltd.’s market cap?
WeLeader Biomedical Co. Ltd.’s market cap is TWD 3.21B.
When is WeLeader Biomedical Co. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were WeLeader Biomedical Co. Ltd.’s earnings last quarter?
WeLeader Biomedical Co. Ltd. released its earnings results on Nov 18, 2026. The company reported TWD 1.635 earnings per share for the quarter.
Is WeLeader Biomedical Co. Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does WeLeader Biomedical Co. Ltd. pay dividends?
WeLeader Biomedical Co. Ltd. pays a ― dividend of TWD 4.1 which represents an annual dividend yield of 5.82%. See more information on WeLeader Biomedical Co. Ltd. dividends here
What is WeLeader Biomedical Co. Ltd.’s EPS estimate?
WeLeader Biomedical Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WeLeader Biomedical Co. Ltd. have?
WeLeader Biomedical Co. Ltd. has 45,478,844 shares outstanding.
What happened to WeLeader Biomedical Co. Ltd.’s price movement after its last earnings report?
WeLeader Biomedical Co. Ltd. reported an EPS of TWD 1.635 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of WeLeader Biomedical Co. Ltd.?
Currently, no hedge funds are holding shares in TW:7713
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
WeLeader Biomedical Co. Ltd.
WeLeader Biomedical Co. Ltd. is primarily involved in the development and distribution of medical diagnostic instruments and related supplies. The company offers specialized products such as integrated systems for serum biochemistry, alongside comprehensive solutions for clinical care and the management of medical information. Established on April 28, 2003, its principal operations are based in Kaohsiung City, Taiwan.